As of 2025-07-19, the Fair Value of Kezar Life Sciences Inc (KZR) is -42.46 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 4.35 USD, the upside of Kezar Life Sciences Inc is -1,076.11%.
With the market price of 4.35 USD and our fair value calculation, Kezar Life Sciences Inc (KZR) is not a good investment. Investing in KZR stocks now will result in a potential loss of 1,076.11%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -41.74 | -54.63 | -68.24 | -101.87 | -83.74 | -70.04 |
| YoY growth | -18.95% | -30.88% | -24.91% | -49.28% | 17.80% | -21.25% |
| Market Cap (mil) | 31.80 |
| P/E | |
| Forward P/E |
| EPS | -8.49 |
| Avg earnings growth rate | -21.25% |
| TTM earnings | -62.08 |